Detection of VDR gene ApaI and TaqI polymorphisms in patients with type 2 diabetes mellitus using PCR-RFLP method in a Turkish population

被引:68
作者
Dilmec, Fuat [1 ]
Uzer, Elmas [2 ]
Akkafa, Feridun [1 ]
Kose, Elif [3 ]
van Kuilenburg, Andre B. P. [4 ,5 ]
机构
[1] Harran Univ, Fac Med, Dept Med Biol, TR-63300 Sanliurfa, Turkey
[2] Harran Univ, Fac Med, Dept Internal Med, TR-63300 Sanliurfa, Turkey
[3] Harran Univ, Fac Med, Dept Chest Dis, TR-63300 Sanliurfa, Turkey
[4] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands
[5] Univ Amsterdam, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands
关键词
Type 2 diabetes mellitus; Vitamin D receptor gene; Polymorphism; PCR; RFLP; D-RECEPTOR POLYMORPHISMS; VITAMIN-D; BANGLADESHI ASIANS; ASSOCIATION; SUSCEPTIBILITY; OBESITY; CELLS;
D O I
10.1016/j.jdiacomp.2008.12.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes mellitus (T2DM) is by far the most common type of diabetes and is characterized by insulin resistance and altered insulin secretion. Some genes, such as the vitamin D receptor gene (VDR, NM_001017535; GI: 7421), involved in its metabolic pathway have been regarded as good candidates for T2DM. In this study, we investigated whether there was an association of VDR: g.59979G>T or c.1025-49G>T (ApaIG>T) and g.60058T>C or c.1056T>C (TagIT>C) polymorphisms in the 3' untranslated region of VDR with T2DM in a Turkish population. We collected blood samples from 241 individuals (72 patients with T2DM and 169 healthy individuals), and their DNA was isolated. Polymorphisms of the VDR were analyzed by DNA amplification with polymerase chain reaction and endonuclease digestion with ApaI and TaqI. Body mass index was higher in T2DM patients than in control individuals. However, the frequency of g.59979TT genotype in T2DM patients was not significantly increased compared to healthy subjects (37.5% vs. 36.1%, respectively). Although the VDR g.60058CC genotype in T2DM patients (19.4%) was higher than that in healthy individuals (11.2%), there was no significant difference. In the same way, there was no difference between the groups in allele frequencies. In conclusion, our study did not provide evidence for the association of two examined VDR polymorphisms with T2DM in a Turkish population. (C) 2010 Published by Elsevier Inc.
引用
收藏
页码:186 / 191
页数:6
相关论文
共 20 条
[1]  
[Anonymous], 1999, Definition, diagnosis, and classification of diabetes mellitus and its complications: report of a WHO consultation
[2]  
Boullu-Sanchis S, 1999, DIABETES METAB, V25, P150
[3]   Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population [J].
Chang, TJ ;
Lei, HH ;
Yeh, JI ;
Chiu, KC ;
Lee, KC ;
Chen, MC ;
Tai, TY ;
Chuang, LM .
CLINICAL ENDOCRINOLOGY, 2000, 52 (05) :575-580
[4]   Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients [J].
Cyganek, K. ;
Mirkiewicz-Sieradzka, B. ;
Malecki, M. T. ;
Wolkow, P. ;
Skupien, J. ;
Bobrek, J. ;
Czogala, M. ;
Klupa, T. ;
Sieradzki, J. .
ACTA DIABETOLOGICA, 2006, 43 (04) :114-119
[5]   Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians [J].
Hitman, GA ;
Mannan, N ;
McDermott, MF ;
Aganna, E ;
Ogunkolade, BW ;
Hales, CN ;
Boucher, BJ .
DIABETES, 1998, 47 (04) :688-690
[6]   Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population [J].
Malecki, MT ;
Frey, J ;
Moczulski, D ;
Klupa, T ;
Kozek, E ;
Sieradzki, J .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2003, 111 (08) :505-509
[7]   A SIMPLE SALTING OUT PROCEDURE FOR EXTRACTING DNA FROM HUMAN NUCLEATED CELLS [J].
MILLER, SA ;
DYKES, DD ;
POLESKY, HF .
NUCLEIC ACIDS RESEARCH, 1988, 16 (03) :1215-1215
[8]   Vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Indian women [J].
Mitra, Sumegha ;
Desai, Meena ;
Khatkhatay, M. Ikram .
MATURITAS, 2006, 55 (01) :27-35
[9]   Structural organization of the human vitamin D receptor chromosomal gene and its promoter [J].
Miyamoto, K ;
Kesterson, RA ;
Yamamoto, H ;
Taketani, Y ;
Nishiwaki, E ;
Tatsumi, S ;
Inoue, Y ;
Morita, K ;
Takeda, E ;
Pike, JW .
MOLECULAR ENDOCRINOLOGY, 1997, 11 (08) :1165-1179
[10]  
MULLER K, 1992, AUTOIMMUNITY, V14, P37